Log in  First Connection?

VaccinesArchives

Pediatric antibody responses to SARS-CoV-2 after infection and vaccination in Calgary, Canada
Vaccines
 5 min.

 Published on 25/07/2024 |  Original article (Full-text)  | Ricketson Leah J. et al. | BMC Infectious Diseases 2024; 24(1): 696

The World Health Organization declared the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on March 11, 2020, which was followed by the rapid development and uptake of vaccines to protect against COVID-19 infections. The evolution of numerous variants of the original virus and very...

Advertisement
Advertisement

Even though active recommendation for HPV vaccination has restarted, Japan's rates have not recovered
Vaccines
 4 min.

 Published on 18/07/2024 |  Original article (Full-text)  | Asami Yagi et al. | Cancer science 2024; 115(7): 2410-6

Globally in 2020, there were an estimated 600,000 cases of cervical cancer and 340,000 deaths. Cervical cancers result mainly from a sexually transmitted infection with a high‐risk strain of the HPV, of which there are approximately 15 types. The modern nine‐valent HPV vaccine is protective...

Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high‐risk pediatric cancer patients
Vaccines
 6 min.

 Published on 11/07/2024 |  Original article (Full-text)  | Michal Kyr et al. | International Journal of Cancer 2024; AOP: 10.1002/ijc.35062

Cancer remains the primary cause of disease‐related mortality in children and adolescents. Despite significantly better treatment outcomes for most children with cancer, survival for some high‐risk and recurrent/refractory solid tumors remains plateaued for decades. The “cancer precision...

Three novel pentavalent meningococcal vaccines
Vaccines
 2 min.

 Published on 04/07/2024 |  Original article (Full-text)  | Robert Steffen et al. | Journal of travel medicine 2024; 31(1): 1-3

Invasive meningococcal disease (IMD) is an infectious disease with a mortality of 4–20% (pooled 8.3%) and long-term sequelae, which can result in devastating disability. A recent French study about meningococcal meningitis in patients aged ≥18 years (median 30 years) included a follow-up at...

Adverse Cardiovascular Effects of COVID-19 Vaccination: A Systematic Review
Vaccines
 4 min.

 Published on 27/06/2024 |  Original article (Full-text)  | Huang, Jen-Hung MD et al. | Cardiology in Review 2024; 32(4): 314-9

Coronavirus disease 2019 (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Vaccination is the most effective measure for controlling diseases such as COVID-19, and nearly half of the world population have received at least 1 dose of a COVID-19 vaccine thus...